-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, H8tnj1H56l3iSV6Eadegye1akYHXioF4jjCDwUXYWP6DK4mCYvJTIgAQYVd20sCR AJGJff5E3nG39PZHsj3sXw== 0000912057-00-005219.txt : 20000211 0000912057-00-005219.hdr.sgml : 20000211 ACCESSION NUMBER: 0000912057-00-005219 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20000210 GROUP MEMBERS: ABBOTT LABORATORIES STOCK RETIREMENT TRUST GROUP MEMBERS: GARY P. COUGHLAN GROUP MEMBERS: GREG W. LINDER GROUP MEMBERS: THOMAS M. WASCOE SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: ABBOTT LABORATORIES CENTRAL INDEX KEY: 0000001800 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 360698440 STATE OF INCORPORATION: IL FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: SEC FILE NUMBER: 005-10519 FILM NUMBER: 532394 BUSINESS ADDRESS: STREET 1: 100 ABBOTT PARK ROAD STREET 2: D-322 AP6D CITY: ABBOTT PARK STATE: IL ZIP: 60064-3500 BUSINESS PHONE: 8479376100 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: ABBOTT LABORATORIES STOCK RETIREMENT TRUST CENTRAL INDEX KEY: 0000918392 STANDARD INDUSTRIAL CLASSIFICATION: UNKNOWN SIC - 0000 [0000] STATE OF INCORPORATION: IL FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: ONE ABBOTT PARK ROAD CITY: ABBOTT PARK STATE: IL ZIP: 60064-3500 BUSINESS PHONE: 708-937-6100 MAIL ADDRESS: STREET 1: AP6D, D-322 STREET 2: ONE ABBOTT PARK ROAD CITY: ABBOTT PARK STATE: IL ZIP: 60064-3500 SC 13G/A 1 SC 13G/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 21)* Abbott Laboratories ------------------------------------------------------------ (Name of Issuer) Common Stock without par value ------------------------------------------------------------ (Title of Class of Securities) 002824 10 0 ---------------------------------------- (CUSIP Number) *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). (Continued on following page(s)) Page 1 of 12 Pages - ------------------------ --------------------- CUSIP No. 002824 10 0 13G Page 2 of 12 Pages - ------------------------ --------------------- - ------------------------------------------------------------------------------ 1 NAME OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON Abbott Laboratories Stock Retirement Trust I.R.S. Identification No. 36-6047554 - ------------------------------------------------------------------------------ 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) / / (b) /X/ - ------------------------------------------------------------------------------ 3 SEC USE ONLY - ------------------------------------------------------------------------------ 4 CITIZENSHIP OR PLACE OF ORGANIZATION Illinois ---------------------------------------------------------- 5 SOLE VOTING POWER NUMBER OF 0 ---------------------------------------------------------- SHARES 6 SHARED VOTING POWER BENEFICIALLY OWNED BY 102,256,673 ---------------------------------------------------------- EACH 7 SOLE DISPOSITIVE POWER REPORTING PERSON 0 ---------------------------------------------------------- WITH 8 SHARED DISPOSITIVE POWER 102,256,673 - ------------------------------------------------------------------------------ 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 102,256,673 - ------------------------------------------------------------------------------ 10 CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* - ------------------------------------------------------------------------------ 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 6.6% - ------------------------------------------------------------------------------ 12 TYPE OF REPORTING PERSON* EP - ------------------------------------------------------------------------------ *SEE INSTRUCTIONS - ------------------------ --------------------- CUSIP No. 002824 10 0 13G Page 3 of 12 Pages - ------------------------ --------------------- - ------------------------------------------------------------------------------ 1 NAME OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON Gary P. Coughlan ###-##-#### - ------------------------------------------------------------------------------ 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) / / (b) /X/ - ------------------------------------------------------------------------------ 3 SEC USE ONLY - ------------------------------------------------------------------------------ 4 CITIZENSHIP OR PLACE OF ORGANIZATION United States - ------------------------------------------------------------------------------ 5 SOLE VOTING POWER 230,620 shares - (Does not include shares held in NUMBER OF direct the Abbott Laboratories Stock Retirement Trust for the benefit of the reporting person.) ---------------------------------------------------------- SHARES 6 SHARED VOTING POWER BENEFICIALLY OWNED BY 105,321,505 - See Attached Exhibit 1 ---------------------------------------------------------- EACH 7 SOLE DISPOSITIVE POWER REPORTING 230,620 shares (see note in 5 above) PERSON direct ---------------------------------------------------------- WITH 8 SHARED DISPOSITIVE POWER 105,321,505 - as Co-Trustee, Abbott Laboratories Stock Retirement Trust. - ------------------------------------------------------------------------------ 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 105,977,734 - (Total of 5 + 6 + 425,609 shares - right to acquire by exercise of stock options.) - ------------------------------------------------------------------------------ 10 CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* - ------------------------------------------------------------------------------ 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 6.8% - ------------------------------------------------------------------------------ 12 TYPE OF REPORTING PERSON* IN - ------------------------------------------------------------------------------ *SEE INSTRUCTIONS - ------------------------ --------------------- CUSIP No. 002824 10 0 13G Page 4 of 12 Pages - ------------------------ --------------------- - ------------------------------------------------------------------------------ 1 NAME OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON Greg W. Linder ###-##-#### - ------------------------------------------------------------------------------ 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) / / (b) /X/ - ------------------------------------------------------------------------------ 3 SEC USE ONLY - ------------------------------------------------------------------------------ 4 CITIZENSHIP OR PLACE OF ORGANIZATION United States - ------------------------------------------------------------------------------ 5 SOLE VOTING POWER 14,272 shares - (Does not include shares held in NUMBER OF direct the Abbott Laboratories Stock Retirement Trust for the benefit of the reporting person.) ---------------------------------------------------------- SHARES 6 SHARED VOTING POWER BENEFICIALLY OWNED BY 105,321,505 - See Attached Exhibit 1 ---------------------------------------------------------- EACH 7 SOLE DISPOSITIVE POWER REPORTING direct 14,272 shares (see note in 5 above) PERSON ---------------------------------------------------------- WITH 8 SHARED DISPOSITIVE POWER 105,321,505 - as Co-Trustee, Abbott Laboratories Stock Retirement Trust. - ------------------------------------------------------------------------------ 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 105,397,147 - (Total of 5 + 6 + 61,370 shares - right to acquire by exercise of stock options.) - ------------------------------------------------------------------------------ 10 CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* - ------------------------------------------------------------------------------ 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 6.8% - ------------------------------------------------------------------------------ 12 TYPE OF REPORTING PERSON* IN - ------------------------------------------------------------------------------ *SEE INSTRUCTIONS - ------------------------ --------------------- CUSIP No. 002824 10 0 13G Page 5 of 12 Pages - ------------------------ --------------------- - ------------------------------------------------------------------------------ 1 NAME OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON Thomas M. Wascoe ###-##-#### - ------------------------------------------------------------------------------ 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) / / (b) /X/ - ------------------------------------------------------------------------------ 3 SEC USE ONLY - ------------------------------------------------------------------------------ 4 CITIZENSHIP OR PLACE OF ORGANIZATION United States - ------------------------------------------------------------------------------ 5 SOLE VOTING POWER 20,000 shares - (Does not include shares held in NUMBER OF direct the Abbot Laboratories Stock Retirement Trust for the benefit of the reporting person.) ---------------------------------------------------------- SHARES 6 SHARED VOTING POWER BENEFICIALLY OWNED BY 105,321,505 - See Attached Exhibit 1 ---------------------------------------------------------- EACH 7 SOLE DISPOSITIVE POWER REPORTING 20,000 shares (see note in 5 above) PERSON direct ---------------------------------------------------------- WITH 8 SHARED DISPOSITIVE POWER 105,321,505 - as Co-Trustee, Abbott Laboratories Stock Retirement Trust. - ------------------------------------------------------------------------------ 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 105,392,239 - (Total of 5 + 6 + 50,734 shares - right to acquire by exercise of stock options.) - ------------------------------------------------------------------------------ 10 CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* - ------------------------------------------------------------------------------ 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 6.8% - ------------------------------------------------------------------------------ 12 TYPE OF REPORTING PERSON* IN - ------------------------------------------------------------------------------ *SEE INSTRUCTIONS Item 1(a) Name of Issuer: Abbott Laboratories Item 1(b) Address of Issuer's Principal Executive Offices: 100 Abbott Park Road Abbott Park, Illinois 60064-6400 Item 2(a) Name of Persons Filing: Abbott Laboratories Stock Retirement Trust Gary P. Coughlan Greg W. Linder Thomas M. Wascoe Item 2(b) Address of Principal Business Office: 100 Abbott Park Road Abbott Park, Illinois 60064-6400 Item 2(c) Citizenship: Abbott Laboratories Stock Retirement Trust - Illinois. Gary P. Coughlan, Greg W. Linder, and Thomas M. Wascoe - United States Item 2(d) Title of Class of Securities: Common shares without par value Item 2(e) CUSIP Number: 002824 10 0 Item 3. If this statement is filed pursuant to Section 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is an: [X] An employee benefit plan or endowment fund in accordance with Rule 13d-1 (b)(1)(ii)(F). Page 6 of 12 pages Item 4. Ownership (a) (See cover pages 2, 3, (b) 4 and 5, Items 5 through (c) 9 and 11.) Item 5. Ownership of Five Percent or Less of a Class Not applicable. Item 6. Ownership of More than Five Percent on Behalf of Another Person. The shares owned by the Abbott Laboratories Stock Retirement Trust and the dividends thereon are held for the benefit of participants of the Abbott Laboratories Stock Retirement Plan pursuant to terms of that Plan and the Trust. The Abbott Laboratories Stock Retirement Plan is a qualified profit sharing plan. As of December 31, 1999, there were 36,577 participants with share balances in the Plan. Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person. Not applicable. Item 8. Identification and Classification of Members of the Group. Not applicable. Item 9. Notice of Dissolution of Group. Not applicable. Item 10. Certification. Not applicable. Signature After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. This statement is filed on behalf of each individual listed below pursuant to their agreement. Date: February 9, 2000 ABBOTT LABORATORIES STOCK RETIREMENT TRUST /s/ Gary P. Coughlan ------------------------------ Gary P. Coughlan, Co-Trustee /s/ Greg W. Linder ------------------------------ Greg W. Linder, Co-Trustee /s/ Thomas M. Wascoe ------------------------------ Thomas M. Wascoe, Co-Trustee Page 7 of 12 pages EXHIBIT 1 Schedule 13G Amendment No. 21 Abbott Laboratories Common shares without par value CUSIP Number 002824 10 0 Messrs. Coughlan, Linder, and Wascoe are Co-trustees of the Abbott Laboratories Stock Retirement Trust, committee members of a committee established under the Abbott Laboratories Stock Retirement Trust (Puerto Rico), Trustees of the Abbott Laboratories Employee Benefit Trust, and members of the Abbott Stock Committee for the Abbott Laboratories Ashland Union 401(k) Trust. As such, each of them has shared voting power over the 105,321,505 shares held by those trusts. This total is comprised of the following components:
Number of Shares Name of Trust ---------------- ------------- 102,256,673 Abbott Laboratories Stock Retirement Trust 2,978,507 Abbott Laboratories Stock Retirement Trust (Puerto Rico) 52,000 Abbott Laboratories Employee Benefit Trust 34,325 Abbott Laboratories Ashland Union 401(k) Trust
Page 8 of 12 Pages Disclaimer of Beneficial Ownership under Rule 13d-4 ---------------------------------- The filing of Schedule 13G Amendment 21 on behalf of the Abbott Laboratories Stock Retirement Trust does not constitute an admission that the undersigned is, for purposes of Section 13(d) of the Securities and Exchange Act of 1934, the beneficial owner of any securities covered by the Schedule. Pursuant to Rule 13d-4 of the Act, the undersigned disclaims such ownership with respect to any shares listed therein of which he would not otherwise be deemed to be beneficial owner. /s/ Gary P. Coughlan ---------------------------------- Gary P. Coughlan Date: February 9, 2000 Page 9 of 12 Pages Disclaimer of Beneficial Ownership under Rule 13d-4 ---------------------------------- The filing of Schedule 13G Amendment 21 on behalf of the Abbott Laboratories Stock Retirement Trust does not constitute an admission that the undersigned is, for purposes of Section 13(d) of the Securities and Exchange Act of 1934, the beneficial owner of any securities covered by the Schedule. Pursuant to Rule 13d-4 of the Act, the undersigned disclaims such ownership with respect to any shares listed therein of which he would not otherwise be deemed to be beneficial owner. /s/ Greg W. Linder ---------------------------------- Greg W. Linder Date: February 9, 2000 Page 10 of 12 Pages Disclaimer of Beneficial Ownership under Rule 13d-4 ---------------------------------- The filing of Schedule 13G Amendment 21 on behalf of the Abbott Laboratories Stock Retirement Trust does not constitute an admission that the undersigned is, for purposes of Section 13(d) of the Securities and Exchange Act of 1934, the beneficial owner of any securities covered by the Schedule. Pursuant to Rule 13d-4 of the Act, the undersigned disclaims such ownership with respect to any shares listed therein of which she would not otherwise be deemed to be beneficial owner. /s/ Thomas M. Wascoe ---------------------------------- Thomas M. Wascoe Date: February 9, 2000 Page 11 of 12 Pages EXHIBIT 2 AGREEMENT ABBOTT LABORATORIES STOCK RETIREMENT TRUST SECURITIES AND EXCHANGE COMMISSION SCHEDULE 13G FILINGS The undersigned, being co-trustees of the Abbott Laboratories Stock Retirement Trust (the "Trust"), hereby agree that one Securities and Exchange Commission Schedule 13G (and any required amendment(s) thereto) be filed on their behalf with respect to the Trust's beneficial ownership interest in shares of common stock of Abbott Laboratories. This Agreement may be revoked in writing by any one of the undersigned. /s/ Gary P. Coughlan Date: February 9, 2000 ---------------------------------- Gary P. Coughlan /s/ Greg W. Linder ---------------------------------- Greg W. Linder /s/ Thomas M. Wascoe ---------------------------------- Thomas M. Wascoe Page 12 of 12 Pages
-----END PRIVACY-ENHANCED MESSAGE-----